N/A
Completed N=12
Medtronic MiniMed Implantable Insulin Pump
Source: ClinicalTrials.gov NCT00298740 ↗Enrolled (actual)
12
Serious AEs
8.3%
Results posted
Sep 2017
Primary outcomePrimary: Glucose Control as Assessed by Mean Glucose Levels
Summary
This research is being done to find out whether subjects previously treated with the implantable insulin pump (IIP) therapy, and now taking insulin by injection, will benefit from re-implantation of IIP. The investigators will see if IIP causes more stable control of blood sugar, with fewer highs and lows. People with type 1 diabetes previously implanted with the MiniMed Implantable Pump (MIP) model 2000 at Johns Hopkins may join this study.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Glucose Control as Assessed by Mean Glucose Levels |
— | — |
Eligibility Criteria
Inclusion Criteria
- People with type 1 diabetes previously implanted with the MiniMed Implantable Pump model 2000 at Johns Hopkins may join this study.
Exclusion Criteria
- Anyone not previously implanted with the MiniMed Implantable Pump model 2000 at Johns Hopkins.
Data sourced from ClinicalTrials.gov (NCT00298740). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.